Zeo ScientifiX (ZEOX) Common Equity (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Common Equity of $712000.0 for Q2 2026, up 133.9% year-over-year from $304397.4 in Q2 2025, and up 285.9% quarter-over-quarter from -$383000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Common Equity (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Common Equity history runs 15 years deep, the most recent figure standing at $712000.0 for Q2 2026.
- In Q2 2026, Common Equity rose 133.9% year-over-year to $712000.0; the TTM figure through Apr 2026 stood at $712000.0 (up 133.9% YoY), while the FY2025 annual figure was -$1.4 million, up 13.91% from the prior year.
- Common Equity for Q2 2026 stood at $712000.0, up from -$383000.0 in the prior quarter.
- The five-year high for Common Equity was $1.9 million in Q4 2022, with the low at -$4.6 million in Q3 2022.
- The 5-year median for Common Equity is -$1.5 million (2024), against an average of -$1.4 million.
- The sharpest annual moves came in 2022 and 2024: Common Equity jumped 170.87% in 2022, then slumped 1123.02% in 2024.
- Zeo ScientifiX's Common Equity stood at $1.9 million in 2022, then tumbled by 165.7% to -$1.2 million in 2023, then sank by 33.2% to -$1.7 million in 2024, then rose by 13.91% to -$1.4 million in 2025, then soared by 150.04% to $712000.0 in 2026.
- Business Quant data shows ZEOX's Common Equity at $712000.0 in Q2 2026, -$383000.0 in Q1 2026, and -$1.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.35 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 757.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.79 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 22.38 Bn |
| 10 | Zeo ScientifiX | 11.02 Mn | 9.17 Mn | 2.06 Mn | 712,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 712,000.00 |
| Jan 31, 2026 | -383,000.00 |
| Oct 31, 2025 | -1.42 Mn |
| Jul 31, 2025 | -2.31 Mn |
| Apr 30, 2025 | -2.10 Mn |
| Jan 31, 2025 | -1.81 Mn |
| Oct 31, 2024 | -1.65 Mn |
| Jul 31, 2024 | -1.42 Mn |
| Apr 30, 2024 | -1.70 Mn |
| Jan 31, 2024 | -1.51 Mn |
| Oct 31, 2023 | -1.24 Mn |
| Jul 31, 2023 | -1.02 Mn |
| Apr 30, 2023 | -139,000.00 |
| Jan 31, 2023 | 677,000.00 |
| Oct 31, 2022 | 1.89 Mn |
| Jul 31, 2022 | -4.61 Mn |
| Apr 30, 2022 | -4.19 Mn |
| Jan 31, 2022 | -3.29 Mn |
| Oct 31, 2021 | -2.67 Mn |
| Jul 31, 2021 | -2.46 Mn |